Blue Wolf Capital Partners LLC, a New York-based private equity firm, has entered into an agreement to acquire Civco Radiotherapy, a provider of radiotherapy patient positioning and immobilization equipment, from Roper Technologies Inc. (NYSE: ROP).
Jeremy Kogler, partner at Blue Wolf Capital, said, “We are incredibly pleased to partner with CIVCO Radiotherapy’s leadership team to further strengthen the company’s longstanding leading position in mission-critical radiotherapy products. We look forward to many years of continued growth at Civco Radiotherapy.”
“We are pleased to have found a trusted partner in Blue Wolf with the skills, expertise and capital to support our significant growth goals and mission of improving outcomes for patients and healthcare providers worldwide,” said Nat Geissel, current president of Civco Radiotherapy, who will be named CEO of the company at transaction close. “Blue Wolf has a track record of successfully managing businesses. I’m confident their team will help to enhance our production capabilities and distribution efficiencies to meet the needs of patients and healthcare providers globally.”
“Civco Radiotherapy is a leader in the provision of radiotherapy positioning equipment,” said Shashank Patel, principal at Blue Wolf Capital. “The company has a rich history of improving the patient experience and clinical outcomes for cancer patients globally. We believe Civco Radiotherapy is well positioned to further help clinicians offer more targeted and accurate treatment to patients as innovations in the radiotherapy space continue. We look forward to working with Nat and his team to build on its mission of improving outcomes and quality care for patients.”